95 related articles for article (PubMed ID: 19276405)
21. Risk of Respiratory Distress Syndrome and Efficacy of Glucocorticoids: Are They the Same in the Normally Grown and Growth-Restricted Infant?
McGillick EV; Orgeig S; Williams MT; Morrison JL
Reprod Sci; 2016 Nov; 23(11):1459-1472. PubMed ID: 27549917
[TBL] [Abstract][Full Text] [Related]
22. The effect of betamethasone treatment on neuroactive steroid synthesis in a foetal Guinea pig model of growth restriction.
McKendry AA; Palliser HK; Yates DM; Walker DW; Hirst JJ
J Neuroendocrinol; 2010 Mar; 22(3):166-74. PubMed ID: 20041984
[TBL] [Abstract][Full Text] [Related]
23. Intrauterine growth restriction--diagnosis and management.
Sheridan C
Aust Fam Physician; 2005 Sep; 34(9):717-23. PubMed ID: 16184202
[TBL] [Abstract][Full Text] [Related]
24. Contraction stress test versus ductus venosus Doppler evaluation for the prediction of adverse perinatal outcome in growth-restricted fetuses with non-reassuring non-stress test.
Figueras F; MartÃnez JM; Puerto B; Coll O; Cararach V; Vanrell JA
Ultrasound Obstet Gynecol; 2003 Mar; 21(3):250-5. PubMed ID: 12666219
[TBL] [Abstract][Full Text] [Related]
25. Renal effects of antenatally or postnatally administered steroids.
Cattarelli D; Chirico G; Simeoni U
Pediatr Med Chir; 2002; 24(2):157-62. PubMed ID: 11987524
[TBL] [Abstract][Full Text] [Related]
26. Antenatal steroid therapy: have we undervalued the risks?
Cavalieri RL; Cohen WR
J Matern Fetal Neonatal Med; 2006 May; 19(5):265-9. PubMed ID: 16753765
[TBL] [Abstract][Full Text] [Related]
27. Customised assessment of fetal growth potential: implications for perinatal care.
Gardosi J
Arch Dis Child Fetal Neonatal Ed; 2012 Sep; 97(5):F314-7. PubMed ID: 22684160
[TBL] [Abstract][Full Text] [Related]
28. Exogenous antenatal glucocorticoid treatment reduces susceptibility for hippocampal kindled and maximal electroconvulsive seizures in infant rats.
Young NA; Teskey GC; Henry LC; Edwards HE
Exp Neurol; 2006 Apr; 198(2):303-12. PubMed ID: 16445912
[TBL] [Abstract][Full Text] [Related]
29. [Intrauterine growth retardation in preterm labor and delivery].
Gogiia TE; Kintraia NP
Georgian Med News; 2005 Dec; (129):30-3. PubMed ID: 16444024
[TBL] [Abstract][Full Text] [Related]
30. Neonatal management of the growth-restricted infant.
Yu VY; Upadhyay A
Semin Fetal Neonatal Med; 2004 Oct; 9(5):403-9. PubMed ID: 15691776
[TBL] [Abstract][Full Text] [Related]
31. Fetal and neonatal hepatic tumors.
Isaacs H
J Pediatr Surg; 2007 Nov; 42(11):1797-803. PubMed ID: 18022426
[TBL] [Abstract][Full Text] [Related]
32. Perinatal circulating visfatin levels in intrauterine growth restriction.
Malamitsi-Puchner A; Briana DD; Boutsikou M; Kouskouni E; Hassiakos D; Gourgiotis D
Pediatrics; 2007 Jun; 119(6):e1314-8. PubMed ID: 17502346
[TBL] [Abstract][Full Text] [Related]
33. Reactive oxygen species are involved in lipopolysaccharide-induced intrauterine growth restriction and skeletal development retardation in mice.
Xu DX; Chen YH; Zhao L; Wang H; Wei W
Am J Obstet Gynecol; 2006 Dec; 195(6):1707-14. PubMed ID: 16769026
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of perinatal outcome using individualized growth assessment: comparison with conventional methods.
Ariyuki Y; Hata T; Kitao M
Pediatrics; 1995 Jul; 96(1 Pt 1):36-42. PubMed ID: 7596719
[TBL] [Abstract][Full Text] [Related]
35. Enhancing functional maturity before preterm birth.
Hallman M; Peltoniemi O; Kari MA
Neonatology; 2010 Jun; 97(4):373-8. PubMed ID: 20551706
[TBL] [Abstract][Full Text] [Related]
36. The effects of antenatal glucocorticoid exposure on fetal and neonatal skin maturation.
August D; Kandasamy Y
J Perinat Med; 2017 Nov; 45(8):969-975. PubMed ID: 28170341
[TBL] [Abstract][Full Text] [Related]
37. Antenatal glucocorticoids supplementation and central nervous system development.
Gazzolo D; Serpero LD; Frigiola A; Abella R; Dro Giamberti A; Li Volti G; Michetti F
Curr Drug Metab; 2013 Feb; 14(2):160-6. PubMed ID: 22935060
[TBL] [Abstract][Full Text] [Related]
38. Antenatal Glucocorticoid Administration Promotes Cardiac Structure and Energy Metabolism Maturation in Preterm Fetuses.
Sakurai K; Takeba Y; Osada Y; Mizuno M; Tsuzuki Y; Aso K; Kida K; Ohta Y; Ootaki M; Iiri T; Hokuto I; Shimizu N; Matsumoto N
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077580
[TBL] [Abstract][Full Text] [Related]
39. Intrauterine growth restriction: impact on cardiovascular development and function throughout infancy.
Cohen E; Wong FY; Horne RS; Yiallourou SR
Pediatr Res; 2016 Jun; 79(6):821-30. PubMed ID: 26866903
[TBL] [Abstract][Full Text] [Related]
40. Effect of perinatal glucocorticoids on vascular health and disease.
Millage AR; Latuga MS; Aschner JL
Pediatr Res; 2017 Jan; 81(1-1):4-10. PubMed ID: 27656772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
